Alessandra F. Oortwijn - Publications

Association between endo-histological outcomes and colonic mucosal transcriptomic profiles in patients with ulcerative colitis receiving filgotinib.

Journal: Journal of Crohn's & colitis

Published: January 22, 2026

Factors associated with response to filgotinib and the prognostic power of faecal calprotectin for ulcerative colitis in the phase 2b/3 SELECTION trial.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: December 20, 2024

Mediators of Filgotinib Treatment Effects in Ulcerative Colitis: Exploring Circulating Biomarkers in the Phase 2b/3 SELECTION Study.

Journal: Inflammatory bowel diseases

Published: June 30, 2024

Distinct trajectories of symptomatic response in ulcerative colitis during filgotinib therapy: A post hoc analysis from the SELECTION study.

Journal: United European gastroenterology journal

Published: April 23, 2024

Benefit-Risk Trade-offs and Patient Preferences for Therapy Selection in Ulcerative Colitis: a Multicountry Preference Study.

Journal: Inflammatory bowel diseases

Published: March 05, 2024

Filgotinib induction-study baseline characteristics of patients with ulcerative colitis who achieve sustained corticosteroid-free remission: post hoc analysis of the phase 2b/3 SELECTION study.

Journal: Intestinal research

Published: January 17, 2024

Withdrawal and Re-treatment with Filgotinib in Ulcerative Colitis: Post Hoc Analyses of the Phase 2b/3 SELECTION and SELECTIONLTE Studies.

Journal: Journal of Crohn's & colitis

Published: August 04, 2023

Impact of Concomitant Thiopurine on the Efficacy and Safety of Filgotinib in Patients with Ulcerative Colitis: Post Hoc Analysis of the Phase 2b/3 SELECTION Study.

Journal: Journal of Crohn's & colitis

Published: June 25, 2023

Integrated safety analysis of filgotinib for ulcerative colitis: Results from SELECTION and SELECTIONLTE.

Journal: Alimentary pharmacology & therapeutics

Published: April 13, 2023

Efficacy of Filgotinib in Patients with Ulcerative Colitis by Line of Therapy in the Phase 2b/3 SELECTION Trial.

Journal: Journal of Crohn's & colitis

Published: March 17, 2023

Filgotinib Improved Health-Related Quality of Life and Led to Comprehensive Disease Control in Individuals with Ulcerative Colitis: Data from the SELECTION Trial.

Journal: Journal of Crohn's & colitis

Published: February 09, 2023

Declining Enrolment and Other Challenges in IBD Clinical Trials: Causes and Potential Solutions.

Journal: Journal of Crohn's & colitis

Published: November 21, 2022